Explore Our Affordable Courses

Click Here

Indigenous Vaccine Against Dengue

Context: 

Indian drugmakers Serum Institute of India and Panacea Biotec have submitted their responses to the Indian Council of Medical Research (ICMR) for an Expression of Interest (EOI) to collaborate on Phase 3 clinical trials for India’s first dengue vaccine. 

About Dengue:

  • Dengue (break-bone fever) is a viral infection caused by dengue virus (DENV) that spreads from mosquitoes to people. 
  • It is more common in tropical and subtropical climates.
  • Symptoms: High fever, Severe headache, Pain behind the eye, Muscle and joint pains, Nausea.
  • Treatment: There is no specific treatment for dengue. 
  • The ICMR says the den­gue viral disease causes significant morbidity and mortality across the globe and in India, 2 to 2.5 lakh cases are reported annually.
  • In 2019, the World Health Organization (WHO) identified dengue to be one among the top 10 global health threats.

News Source: The Hindu

To get PDF version, Please click on "Print PDF" button.

Need help preparing for UPSC or State PSCs?

Connect with our experts to get free counselling & start preparing

Download October 2024 Current Affairs.   SRIJAN 2025 Program (Prelims+Mains) !     Current Affairs Plus By Sumit Sir   UPSC Prelims Test Series 2025

THE MOST
LEARNING PLATFORM

Learn From India's Best Faculty

      

Download October 2024 Current Affairs.   SRIJAN 2025 Program (Prelims+Mains) !     Current Affairs Plus By Sumit Sir   UPSC Prelims Test Series 2025

Quick Revise Now !
AVAILABLE FOR DOWNLOAD SOON
UDAAN PRELIMS WALLAH
Comprehensive coverage with a concise format
Integration of PYQ within the booklet
Designed as per recent trends of Prelims questions
हिंदी में भी उपलब्ध
Quick Revise Now !
UDAAN PRELIMS WALLAH
Comprehensive coverage with a concise format
Integration of PYQ within the booklet
Designed as per recent trends of Prelims questions
हिंदी में भी उपलब्ध

<div class="new-fform">







    </div>

    Subscribe our Newsletter
    Sign up now for our exclusive newsletter and be the first to know about our latest Initiatives, Quality Content, and much more.
    *Promise! We won't spam you.
    Yes! I want to Subscribe.